摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-氯-1-(2-甲氧基苯基)-1-戊酮 | 43228-96-2

中文名称
5-氯-1-(2-甲氧基苯基)-1-戊酮
中文别名
——
英文名称
5-chloro-1-(2-methoxyphenyl)-1-pentanone
英文别名
5-Chlor-2'-methoxy-valerophenon;5-Chloro-1-(2-methoxyphenyl)-1-oxopentane;5-chloro-1-(2-methoxyphenyl)pentan-1-one
5-氯-1-(2-甲氧基苯基)-1-戊酮化学式
CAS
43228-96-2
化学式
C12H15ClO2
mdl
——
分子量
226.703
InChiKey
GHMGFAPMZJCMOW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    15
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2914700090

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-氯-1-(2-甲氧基苯基)-1-戊酮氢溴酸 作用下, 以 为溶剂, 反应 4.0h, 生成 5-chloro-1-(2-hydroxyphenyl)-1-pentanone
    参考文献:
    名称:
    Synthesis and Structure−Affinity Relationships of 1-[ω-(4-Aryl-1-piperazinyl)alkyl]-1-aryl Ketones as 5-HT7 Receptor Ligands
    摘要:
    Structural requirements for 5-HT7 receptor affinity and selectivity over that for the 5-HT1A receptor were studied on a series of 1-[omega-(4-aryl-1-piperazinyl)alkyl] - I-aryl ketones. The presence of a hydroxy or methoxy substituent on aryl ketone moiety, alkyl chain length, and the nature of N-1-piperazine substituent were explored. 6-[4-(3-Benzisoxazolyl)-l-piperazinyl]-1-(2-hydroxyphenyl)-1-hexanone (40) and its methoxy analogue 43 exhibited high 5-HT7 receptor affinities (K-i = 2.93 nM and 0.90 nM, respectively) and agonist properties when tested for 5-HT7 receptor-mediated relaxation of substance P-induced guinea-pig ileum contraction.
    DOI:
    10.1021/jm020994z
  • 作为产物:
    描述:
    5-chloro-1-(2-methoxyphenyl)-1-pentanol 在 jones' reagent 作用下, 以 丙酮 为溶剂, 反应 6.0h, 以70%的产率得到5-氯-1-(2-甲氧基苯基)-1-戊酮
    参考文献:
    名称:
    Synthesis and Structure−Affinity Relationships of 1-[ω-(4-Aryl-1-piperazinyl)alkyl]-1-aryl Ketones as 5-HT7 Receptor Ligands
    摘要:
    Structural requirements for 5-HT7 receptor affinity and selectivity over that for the 5-HT1A receptor were studied on a series of 1-[omega-(4-aryl-1-piperazinyl)alkyl] - I-aryl ketones. The presence of a hydroxy or methoxy substituent on aryl ketone moiety, alkyl chain length, and the nature of N-1-piperazine substituent were explored. 6-[4-(3-Benzisoxazolyl)-l-piperazinyl]-1-(2-hydroxyphenyl)-1-hexanone (40) and its methoxy analogue 43 exhibited high 5-HT7 receptor affinities (K-i = 2.93 nM and 0.90 nM, respectively) and agonist properties when tested for 5-HT7 receptor-mediated relaxation of substance P-induced guinea-pig ileum contraction.
    DOI:
    10.1021/jm020994z
点击查看最新优质反应信息

文献信息

  • US5739336A
    申请人:——
    公开号:US5739336A
    公开(公告)日:1998-04-14
  • [EN] 1,3,8-TRIAZA- AND 3,8-DIAZA-1-OXASPIRO(4,5)DECANE DERIVATIVES<br/>[FR] DERIVES DE 1,3,8-TRIAZA ET 3,8-DIAZA-1-OXASPIRO(4,5)-DECANE
    申请人:F.HOFFMANN-LA ROCHE AG
    公开号:WO1997000872A1
    公开(公告)日:1997-01-09
    (EN) Heterocyclic compounds of Formula (I) in which n is 2, 3, 4, 5 or 6; t is 1, 2, 3 or 4; u is 0 or 1 (provided that t is not 1 when u is 0); X is O or N(R4), in which R4 is hydro, (C1-4)alkyl, or aryl; Y and Z are independently C(O), C(S) or CH2 (provided that Y and Z are not both CH2); R1, R2, and R3 are as defined in the specification; and their pharmaceutically acceptable salts and $i(N)-oxides, formulations containing them, their uses as therapeutic agents, and their synthesis. The compounds of this invention are selective 5-HT2C receptor antagonists.(FR) La présente invention se rapporte à des composés hétérocycliques de formule générale (I), dans laquelle n vaut 2, 3, 4, 5 ou 6; t vaut 1, 2 ,3 ou 4; u vaut 0 ou 1 (à condition que t ne soit pas égal à 1 lorsque u vaut 0); X représente O ou N(R4) dans lequel R4 représente hydro, alkyle (C1-4) ou aryle; Y et Z représentent indépendamment C(O), C(S) ou CH2 (à condition que Y et Z ne représentent pas tous les deux CH2); R1, R2 et R3 sont tels que définis dans la description; ainsi qu'à leurs sels et $i(N)-oxides pharmaceutiquement acceptables, les formulations les contenant, leur utilisation en tant qu'agents thérapeutiques et leur synthèse. Les composés de cette invention sont des antagonistes sélectifs du récepteur 5-HT2C.
  • Synthesis and Structure−Affinity Relationships of 1-[ω-(4-Aryl-1-piperazinyl)alkyl]-1-aryl Ketones as 5-HT<sub>7</sub> Receptor Ligands
    作者:Roberto Perrone、Francesco Berardi、Nicola A. Colabufo、Enza Lacivita、Marcello Leopoldo、Vincenzo Tortorella
    DOI:10.1021/jm020994z
    日期:2003.2.1
    Structural requirements for 5-HT7 receptor affinity and selectivity over that for the 5-HT1A receptor were studied on a series of 1-[omega-(4-aryl-1-piperazinyl)alkyl] - I-aryl ketones. The presence of a hydroxy or methoxy substituent on aryl ketone moiety, alkyl chain length, and the nature of N-1-piperazine substituent were explored. 6-[4-(3-Benzisoxazolyl)-l-piperazinyl]-1-(2-hydroxyphenyl)-1-hexanone (40) and its methoxy analogue 43 exhibited high 5-HT7 receptor affinities (K-i = 2.93 nM and 0.90 nM, respectively) and agonist properties when tested for 5-HT7 receptor-mediated relaxation of substance P-induced guinea-pig ileum contraction.
查看更多